DIANTHUS THERAPEUTICS INC
DNTH·252828108·US·Common Stock·Healthcare - Biotechnology-Activist
DNTH (DIANTHUS THERAPEUTICS INC) is held by 129 institutional investors as of Q1 2026. Largest holders: FMR LLC ($651.9M), BlackRock, Inc. ($266.5M), RA CAPITAL MANAGEMENT, L.P. ($219.2M). Net institutional sentiment: Bullish.
129
Holders
Avg rating(24 Elite)
$3.4B
Total Value
76% (135)
Fund Consensus
102 buying - 32 selling
Who's Trading
InsiderSRSavitz RyanSell $1.0MJul 9, 2026
InsiderSRSavitz RyanSell $1.6MJul 9, 2026
InsiderSRSavitz RyanSell $568KJul 9, 2026
InsiderVMVeness Adam MSell $1.3MJun 17, 2026
InsiderVMVeness Adam MSell $1.1MJun 17, 2026
InsiderRSRandhawa SimratSell $487KJun 1, 2026
InsiderRSRandhawa SimratSell $1.5MJun 1, 2026
InsiderRSRandhawa SimratSell $380KJun 1, 2026
ActivistSISirenia Capital Management LP5.3%May 15, 2026
13F: Insider & Congress:
Showing 1-20 of 135
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer